134 related articles for article (PubMed ID: 34519592)
1.
Stadtlober NP; Flauzino T; Santos LFDRF; Iriyoda TMV; Costa NT; Lozovoy MAB; Reiche EMV; Simão ANC
Autoimmunity; 2021 Dec; 54(8):569-575. PubMed ID: 34519592
[TBL] [Abstract][Full Text] [Related]
2. TGFB1 (rs1800470 and rs1800469) variants are independently associated with disease activity and autoantibodies in rheumatoid arthritis patients.
Iriyoda TMV; Flauzino T; Costa NT; Lozovoy MAB; Reiche EMV; Simão ANC
Clin Exp Med; 2022 Feb; 22(1):37-45. PubMed ID: 34046752
[TBL] [Abstract][Full Text] [Related]
3. Haplotypes of FOXP3 genetic variants are associated with susceptibility, autoantibodies, and TGF-β1 in patients with systemic lupus erythematosus.
Stadtlober NP; Flauzino T; da Rosa Franchi Santos LF; Iriyoda TMV; Costa NT; Lozovoy MAB; Dichi I; Reiche EMV; Simão ANC
Sci Rep; 2021 Mar; 11(1):5406. PubMed ID: 33686190
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
Sayed SK; Galal SH; Herdan OM; Mahran AM
Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
[TBL] [Abstract][Full Text] [Related]
5. Association of Transforming Growth Factor β1 Gene Polymorphisms and Inflammatory Factor Levels with Susceptibility to Sepsis.
Zheng R; Fu Z; Zhao Z
Genet Test Mol Biomarkers; 2021 Mar; 25(3):187-198. PubMed ID: 33734893
[No Abstract] [Full Text] [Related]
6. Association between circulating transforming growth factor-β1 level and polymorphisms in systemic lupus erythematosus and rheumatoid arthritis: A meta-analysis.
Lee YH; Bae SC
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(1):53-59. PubMed ID: 28234629
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women.
Hadj-Ahmed M; Ghali RM; Bouaziz H; Habel A; Stayoussef M; Ayedi M; Hachiche M; Rahal K; Yacoubi-Loueslati B; Almawi WY
Tumour Biol; 2019 Aug; 41(8):1010428319869096. PubMed ID: 31405342
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus.
Schotte H; Willeke P; Rust S; Assmann G; Domschke W; Gaubitz M; Schlüter B
Lupus; 2003; 12(2):86-92. PubMed ID: 12630751
[TBL] [Abstract][Full Text] [Related]
9. The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis.
Hristova M; Kamenarska Z; Dzhebir G; Nikolova S; Hristova R; Mihova K; Vinkov A; Georgiev T; Pozharashka J; Kaneva R; Savov A; Koundurdjiev A; Dourmishev L
Rheumatol Int; 2021 Dec; 41(12):2205-2213. PubMed ID: 34554306
[TBL] [Abstract][Full Text] [Related]
10. IL-6 and TGF-β gene polymorphisms, their serum levels, as well as HLA profile, in patients with systemic lupus erythematosus.
Paradowska-Gorycka A; Roszak M; Stypinska B; Lutkowska A; Walczyk M; Olesinska M; Wajda A; Piotrowski P; Puszczewicz M; Majewski D; Jagodzinski PP
Clin Exp Rheumatol; 2019; 37(6):963-975. PubMed ID: 30943147
[TBL] [Abstract][Full Text] [Related]
11. The association between C509T, T869C, G915C gene polymorphisms of transforming growth factor-β1 and systemic lupus erythematosus risk: A meta-analysis.
Chen N; Dai Y; He J; Zhou M; Sun H; Lin L; Gao F; Lin H; Yan Q
Medicine (Baltimore); 2023 Mar; 102(11):e33321. PubMed ID: 36930071
[TBL] [Abstract][Full Text] [Related]
12. TGFB1 mRNA expression and frequency of the + 869T>C and + 915G>C genetic variants: impact on risk for systemic sclerosis.
Lomeli-Nieto JA; Muñoz-Valle JF; Navarro-Zarza JE; Baños-Hernández CJ; García-Arellano S; Alvarado-Navarro A; Anaya-Macías BU; Oregón-Romero E; Fuentes-Baez CE; Parra-Rojas I; Hernández-Bello J
Clin Exp Med; 2023 Aug; 23(4):1349-1357. PubMed ID: 36464760
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.
Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV
Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus.
Lu LY; Cheng HH; Sung PK; Yeh JJ; Shiue YL; Chen A
J Microbiol Immunol Infect; 2004 Jun; 37(3):145-52. PubMed ID: 15221033
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
[TBL] [Abstract][Full Text] [Related]
16. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease.
Juarez I; Gutierrez A; Vaquero-Yuste C; Molanes-López EM; López A; Lasa I; Gómez R; Martin-Villa JM
J Cell Mol Med; 2021 Jan; 25(2):774-783. PubMed ID: 33274798
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
[TBL] [Abstract][Full Text] [Related]
18. The association between transforming growth factor beta1 polymorphism and susceptibility to pulmonary fibrosis: A meta-analysis (MOOSE compliant).
Xin L; Jiang M; Su G; Xie M; Chen H; Liu X; Xu M; Zhang G; Gong J
Medicine (Baltimore); 2018 Sep; 97(37):e11876. PubMed ID: 30212926
[TBL] [Abstract][Full Text] [Related]
19. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
[TBL] [Abstract][Full Text] [Related]
20. A link between promoter polymorphisms of the transforming growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis.
Grigorova A; Trenova A; Stanilova S
Folia Neuropathol; 2020; 58(4):307-316. PubMed ID: 33480235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
